MBIO News and Press, Mustang Bio Inc. From 05/16/24

2024-05-16 10:53:51 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mustang Bio (NASDAQ: MBIO ) just reported results for the first quarter of 2024. Mustang Bio reported earnings per share of -46 cents. This was above the analyst estimate ...

2024-05-14 09:27:54 ET More on Enveric Biosciences Enveric gains on out-licensing deal of new chemical entities for joint disease treatments Seeking Alpha’s Quant Rating on Enveric Biosciences Historical earnings data for Enveric Biosciences Financial ...

Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...

WORCESTER, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for ...

WORCESTER, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures fo...

A look at the top 10 most actives in the United States Tesla Inc. (TSLA) rose 15.3% to $194.05 on volume of 241,483,966 shares SiNtx Technologies Inc. (SINT) rose 34.9% to $0.0545 on volume of 171,893,463 shares Collective Audience Inc. (CAUD) rose 61.6% to $0.6301 on volume of 156,906,40...

2024-04-15 16:04:24 ET More on Mustang Bio Mustang Bio stock climbs 9% amid drug development update Seeking Alpha’s Quant Rating on Mustang Bio Historical earnings data for Mustang Bio Financial information for Mustang Bio Read the full artic...

2024-04-11 12:24:46 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks can offer some of the most explosive, exciting opportunities on the market. That is, if you find the right one. Viking Therapeutics (NASDAQ: VKTX ) is the...

2024-03-28 11:09:29 ET More on Mustang Bio Seeking Alpha’s Quant Rating on Mustang Bio Historical earnings data for Mustang Bio Financial information for Mustang Bio Read the full article on Seeking Alpha For further details see: Mustang Bi...

Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy in autoimmune diseases is underway and expected to initiate in the fourth quarter of 2024 MB-106 data in B-cell non-Hodgkin lymphoma (NHL) provide a strong founda...